Intercept Pharmaceuticals Announces Completion of Enrollment in FLINT
[at noodls] – NEW YORK, Nov. 12, 2012 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel … moreView todays social media effects on ICPTView the latest stocks trending across Twitter. Click to view dashboard […]